Publications

2023 | Journal of Clinical Oncology

Impact of the HLA immunopeptidome on survival of leukemia patients after unrelated donor transplantation.

Authors:

Crivello P, Arrieta-Bolaños E, He M, Wang T, Fingerson S, Gadalla SM, Paczesny S, Marsh SGE, Lee SJ, Spellman SR, Bolon YT, Fleischhauer K

2023 | Frontiers in Plant Science

Alternative scoring methods of fusarium head blight resistance for genomic assisted breeding.

Authors:

Garcia-Abadillo J, Morales L, Buerstmayr H, Michel S, Lillemo M, Holzapfel J, Hartl L, Akdemir D, Carvalho HF, Isidro-Sánchez J

2023 | Journal of Clinical Oncology

Secondary neoplasms after hematopoietic cell transplant for sickle cell disease.

Authors:

Eapen M, Brazauskas R, Williams DA, Walters MC, St Martin A, Jacbos BL, Antin JH, Bona K, Chaudhury S, Coleman-Cowger VH, DiFronzo NL, Esrick EB, Field JJ, Fitzhugh CD, Kanter J, Kapoor N, Kohn DB, Krishnamurti L, London WB, Pulsipher MA, Talib S, Thompson AA, Waller EK, Wun T, Horowitz MM

2023 | Transplantation and Cellular Therapy

Unrelated stem cell donor HLA match likelihoods in the US Registry incorporating HLA-DPB1 permissive mismatching.

Authors:

Gragert L, Spellman S, Shaw B, Maiers M

2023 | American Journal of Hematology

Association of ABO mismatch with the outcomes of allogeneic hematopoietic cell transplantation for acute leukemia.

Authors:

Guru Murthy GS, Logan BR, Bo-Subait S, Beitinjaneh A, Devine S, Farhadfar N, Gowda L, Hashmi S, Lazarus HM, Nathan S, Sharma A, Yared JA, Stefanski HE, Pulsipher MA, Hsu JW, Switzer GE, Panch SR, Shaw BE

2023 | Haematologica

Efficacy, safety, and cost of mobilization strategies in multiple myeloma: A prospective observational study.

Authors:

Dhakal B, Zhang MJ, Burns LJ, Tang X, Meyer C, Mau LW, Nooka AK, Stadtmauer E, Micallef IN, McGuirk J, Costa L, Juckett MB, Shah N, Champlin RE, Usmani SZ, Farag SS, Nishihori T, Roy V, Bodiford A, Barnes YJ, Drea EJ, Hari P, Hamadani M

2023 | Blood

Chronic conditions, late mortality, and health status after childhood AML: A Childhood Cancer Survivor Study report.

Authors:

Turcotte LM, Whitton JA, Leisenring WM, Howell RM, Neglia JP, Phelan R, Oeffinger KC, Ness KK, Woods WG, Kolb EA, Robison LL, Armstrong GT, Chow EJ

2022 | Transplantation and Cellular Therapy

Three-year outcomes in recipients of mismatched unrelated bone marrow donor transplants using post-transplantation cyclophosphamide: Follow-up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial.

Authors:

Shaw BE, Jimenez-Jimenez AM, Burns LJ, Logan BR, Khimani F, Shaffer BC, Shah NN, Mussetter A, Tang XY, McCarty JM, Alavi A, Farhadfar N, Jamieson K, Hardy NM, Choe H, Ambinder RF, Anasetti C, Perales MA, Spellman SR, Howard A, Komanduri KV, Luznik L, Norkin M, Pidala JA, Ratanatharathorn V, Confer DL, Devine SM, Horowitz MM, Bolaños-Meade J

2022 | Bone Marrow Transplantation

The incidence and impact of clostridioides difficile infection on transplant outcomes in acute leukemia and MDS after allogeneic hematopoietic cell transplant-a CIBMTR study.

Authors:

Ramanathan M, Kim S, He N, Chen M, Hematti P, Abid MB, Rotz SJ, Williams KM, Lazarus HM, Wirk B, Yin DE, Kanakry CG, Perales MA, Chemaly RF, Dandoy CE, Riches M, Ustun C

2022 | Transplantation and Cellular Therapy

Haploidentical versus matched unrelated donor transplants using post-transplant cyclophosphamide for lymphomas.

Authors:

Mussetti A, Kanate AS, Wang T, He M, Hamadani M, Sr HF, Boumendil A Sr, Glass B, Castagna L, Dominietto A, McGuirk J, Blaise D, Gülbas Z, Diez-Martin J, Marsh SGE, Paczesny S, Gadalla SM, Dreger P, Zhang MJ, Spellman SR, Lee SJ, Bolon Y-T, Sureda A

2022 | Hematology / the Education Program of t...

Hematology 2022-What is complete HLA match in 2022?

Authors:

Spellman SR

2022 | Blood Advances

Shared graft-vs-leukemia minor histocompatibility antigens in DISCOVeRY-BMT.

Authors:

Olsen KS, Jadi O, Dexheimer S, Bortone D, Vensko SP, Bennett S, Tang H, Diiorio M, Saran T, Dingfelder D, Zhu Q, Wang Y, Haiman CA, Pooler L, Sheng X, Webb A, Pasquini MC, McCarthy PL, Spellman SR, Weimer E, Hahn T, Sucheston-Campbell L, Armistead P, Vincent B

2022 | Transplantation and Cellular Therapy

Adapting the HCT-CI definitions for children, adolescents, and young adults with hematologic malignancies undergoing allogeneic hematopoietic cell transplantation.

Authors:

Friend BD, Broglie L, Logan BR, Chhabra S, Bupp C, Schiller G, Beitinjaneh A, Perez MAD, Guilcher G, Hashem H, Hildebrandt GC, Krem MM, Lazarus HM, Nishihori T, Nusrat R, Rotz SJ, Wirk B, Wieduwilt M, Pasquini M, Savani BN, Stadtmauer EA, Sorror ML, Thakar MS

2022 | Transplantation and Cellular Therapy

Prognostic biomarkers for hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) in myeloablative allogeneic hematopoietic cell transplantation: Results from the BMT CTN 1202 study.

Authors:

Putta S, Young BA, Levine J, Reshef R, Nakamura R, Strouse C, Perales M, Howard A, Pine P, Shi J, Zhang P, Ho VT, Saber W

2022 | Transplantation and Cellular Therapy

Expanded HCT-CI definitions capture comorbidity better for younger patients of allogeneic HCT for nonmalignant diseases.

Authors:

Broglie L, Friend BD, Chhabra S, Logan BR, Bupp C, Schiller G, Savani BN, Stadtmauer E, Abraham AA, Aljurf M, Badawy SM, Perez MAD, Guinan EC, Hashem H, Krem MM, Lazarus HM, Rotz SJ, Wirk B, Yared JA, Pasquini M, Thakar MS, Sorror ML

2022 | Transplantation and Cellular Therapy

Harmonizing definitions for diagnostic criteria and prognostic assessment of transplant associated thrombotic microangiopathy: A report on behalf of the European Society for Blood and Marrow Transplantation (EBMT), American Society for Transplantation and Cellular Therapy (ASTCT), Asia-Pacific Blood and Marrow Transplantation Group (APBMT) and the Center for International Blood and Marrow Transplant Research (CIBMTR).

Authors:

Schoettler M, Carreras E, Cho B, Dandoy CE, Ho VT, Jodele S, Moissev I, Sanchez-Ortega I, Srivastava A, Atsuta Y, Carpenter P, Koreth J, Kroger N, Ljungman P, Page K, Popat U, Shaw BE, Sureda A, Soiffer R, Vasu S

2022 | Transplantation and Cellular Therapy

Health-related quality of life outcomes in older hematopoietic cell transplant (HCT) survivors.

Authors:

Hong S, Zhao J, Wang S, Wang H, Lee J-H, Farhadfar N, McGuirk J, Savani BN, Hashmi SK, Stiff P, Khera N, Hahn T, Loren AW, Jaglowski SM, Wood WA, Saber W, Cerny J, Holtan SG, Reynolds J, Deol A, Jim H, Uberti J, Whalen V, Yi JC, Preussler J, Baker KS, Shaw B, Devine S, Syrjala KL, Majhail NS, Wingard JR, Al-Mansour Z

2022 | Transplantation and Cellular Therapy

Characterization and function of cryopreserved bone marrow from deceased organ donors: A potential viable alternative graft source.

Authors:

Johnstone BH, Woods JR, Goebel WS, Gu D, Lin CH, Miller HM, Musall KM, Sherry AM, Bailey BJ, Sims E, Sinn AL, Pollok KE, Spellman S, Auletta JJ, Woods EJ

2022 | Transplantation and Cellular Therapy

Bringing patient and caregivers voices to the clinical trial chorus: A report from the BMT CTN Patient and Caregiver Advocacy Task Force.

Authors:

Vasu S, Holtan SG, Shimamura A, Burnworth T, Whisenton S, Adams S, Nuechterlein B, Mortier N, Foster J, DiFronzo N, Horowitz M, Rizzo D, Foley A

2022 | American Journal of Hematology

Health-related quality of life in reduced-intensity hematopoietic cell transplantation based on donor availability in patients aged 50-75 with advanced myelodysplastic syndrome: BMT CTN 1102.

Authors:

Cusatis R, Martens MJ, Nakamura R, Cutler CS, Saber W, Lee SJ, Logan BR, Shaw BE, Gregory A, D'Souza A, Hamilton BK, Horowitz MM, Flynn KE